ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析

◆英語タイトル:ALK-Abello AS (ALK B) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1166
◆発行会社(調査会社):GlobalData
◆発行日:2020年3月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

ALK-Abello AS (ALK B) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

ALK-Abello AS (ALK), a subsidiary of The Lundbeck Foundation discovers, develops and commercializes immunotherapies for allergy prevention and treatment. The company’s allergy immunotherapy product portfolio includes tablets, sublingual or drop-based vaccines, subcutaneous vaccines; and adrenaline auto-injector to treat severe allergic reactions in emergencies (anaphylaxis). ALK’s research and development pipeline products include sublingual immunotherapy tablets for addressing the ragweed, house dust mite and tree pollen allergy. The company’s products target allergies caused by grass, tree, ragweed, house dust mite, Japanese cedar and venom among others. It has subsidiaries in Europe, North America and Asia-Pacific. ALK is headquartered in Horsholm, Denmark.

ALK-Abello AS Key Recent Developments

Feb 05,2020: ALK releases its 2019 annual report
Nov 07,2019: ALK : Nine-month interim report (Q3) 2019
Aug 13,2019: ALK Abello: Six-month interim report (Q2) 2019
Aug 12,2019: ALK upgrades its full-year financial outlook due to strong growth
Jun 03,2019: As ALK prepares to further extend their SLIT-tablet Portfolio, tablet formulation is seen as key in delivering consistent positive clinical trial results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
ALK-Abello AS – Key Facts
ALK-Abello AS – Key Employees
ALK-Abello AS – Key Employee Biographies
ALK-Abello AS – Major Products and Services
ALK-Abello AS – History
ALK-Abello AS – Company Statement
ALK-Abello AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
ALK-Abello AS – Business Description
Product Category: Other Products and Services
Overview
Performance
Product Category: SCIT/SLIT-drops
Overview
Performance
Product Category: SLIT-tablets
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Performance
R&D Overview
ALK-Abello AS – Corporate Strategy
ALK-Abello AS – SWOT Analysis
SWOT Analysis – Overview
ALK-Abello AS – Strengths
ALK-Abello AS – Weaknesses
ALK-Abello AS – Opportunities
ALK-Abello AS – Threats
ALK-Abello AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ALK-Abello AS, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2020: ALK releases its 2019 annual report
Nov 07, 2019: ALK : Nine-month interim report (Q3) 2019
Aug 13, 2019: ALK Abello: Six-month interim report (Q2) 2019
Aug 12, 2019: ALK upgrades its full-year financial outlook due to strong growth
Jun 03, 2019: As ALK prepares to further extend their SLIT-tablet Portfolio, tablet formulation is seen as key in delivering consistent positive clinical trial results
May 09, 2019: ALK Abello: Three-month interim report (Q1) 2019
Feb 07, 2019: ALK releases its annual report 2018
Jan 15, 2019: ALK’s board of directors to nominate Vincent Warnery as new member of the Board
Jan 11, 2019: ALK appoints new head of product supply
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
ALK-Abello AS, Key Facts
ALK-Abello AS, Key Employees
ALK-Abello AS, Key Employee Biographies
ALK-Abello AS, Major Products and Services
ALK-Abello AS, History
ALK-Abello AS, Other Locations
ALK-Abello AS, Subsidiaries
ALK-Abello AS, Key Competitors
ALK-Abello AS, Ratios based on current share price
ALK-Abello AS, Annual Ratios
ALK-Abello AS, Annual Ratios (Cont...1)
ALK-Abello AS, Annual Ratios (Cont...2)
ALK-Abello AS, Interim Ratios
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
ALK-Abello AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
ALK-Abello AS, Performance Chart (2015 - 2019)
ALK-Abello AS, Ratio Charts
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
ALK-Abello AS, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[ALK-Abello AS (ALK B):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Cingulate Therapeutics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Cingulate Therapeutics LLC (Cingulate) is a clinical stage biopharmaceutical company that develops new drug products for the treatment of attention deficit and hyperactivity disorder. The company’s pipeline products comprise CTX-1301 and CTX-1302 utilize precision timed release (PTR) drug de …
  • Maersk Drilling AS:石油・ガス:M&Aディール及び事業提携情報
    Summary Maersk Drilling A/S (Maersk) formerly Maersk Contractors, a subsidiary of A.P. Moller - Maersk A/S, is an oil and gas company that offers drilling services. The company operates a fleet of drilling barges such as smaller rigs optimized for shallow water drilling and operated on management co …
  • B2W – Companhia Global Do Varejo:企業の戦略・SWOT・財務分析
    B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report Summary B2W - Companhia Global Do Varejo - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • American Airlines Group Inc.:企業の戦略・SWOT・財務情報
    American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report Summary American Airlines Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • AEP Texas Inc:企業の戦略的SWOT分析
    AEP Texas Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Recursion Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Recursion Pharmaceuticals Inc (Recursion Pharmaceuticals) is a biotechnology company that develops novel therapies for the treatment of rare genetic diseases. The company’s pipeline products include novel drugs for various diseases such as ataxia-telangiectasia, cerebral cavernous malformati …
  • Cencosud SA:戦略・SWOT・企業財務分析
    Cencosud SA - Strategy, SWOT and Corporate Finance Report Summary Cencosud SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • TAT Technologies, Ltd.:企業の戦略・SWOT・財務情報
    TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report Summary TAT Technologies, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Perenco Holdings-石油・ガス分野:企業M&A・提携分析
    Summary Perenco Holdings (Perenco) is an independent upstream energy company. It explores for, develops, produces, transports, and stores oil and gas. The company’s oil fields ranges from Northern Europe to Africa and Latin America to Southeast Asia. Through spot sales and long term sales agreements …
  • NTT Data Corporation:企業のM&A・事業提携・投資動向
    NTT Data Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's NTT Data Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • German Cancer Research Center-製薬・医療分野:企業M&A・提携分析
    Summary German Cancer Research Center (DKFZ) is a biomedical research institute that develops therapies for the treatment of cancer patients. The institute’s research programs include translational cancer research, cell biology and tumor biology, imaging and radiooncology, cancer risk factors and pr …
  • Yanbu National Petrochemicals Co (2290):企業の財務・戦略的SWOT分析
    Summary Yanbu National Petrochemicals Co (YANSAB), a subsidiary of Saudi Basic Industries Corp is a manufacturer and distributor of petrochemical products. The company offers products such as ethylene, linear density polyethylene, polypropylene, butene 1, ethylene glycol, polyethylene, butene 2, MTB …
  • 4SC AG (VSC):製薬・医療:M&Aディール及び事業提携情報
    Summary 4SC AG (4SC) is a biopharmaceutical company that discovers and develops small molecule drugs for the treatment of cancer and autoimmune diseases. The company’s product focuses on epigenetics, cancer stem cells and cancer immunotherapy. Its product pipeline comprises therapeutic programs at v …
  • Global Petroleum Ltd (GBP):石油・ガス:M&Aディール及び事業提携情報
    Summary Global Petroleum Ltd (Global Petroleum) is an oil and gas company that offers oil and gas exploration and development services. The company operates through a portfolio of oil and gas projects in offshore Namibia and others. Its Namibian Project is into petroleum and gas exploration and Juan …
  • Crocs, Inc.:企業の戦略・SWOT・財務情報
    Crocs, Inc. - Strategy, SWOT and Corporate Finance Report Summary Crocs, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • MakeMyTrip Limited:企業の戦略・SWOT・財務分析
    MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report Summary MakeMyTrip Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • LPL Financial Holdings Inc (LPLA):企業の財務・戦略的SWOT分析
    LPL Financial Holdings Inc (LPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Gilat Satellite Networks Ltd. (GILT):企業の財務・戦略的SWOT分析
    Gilat Satellite Networks Ltd. (GILT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Gazprom (GAZP):電力:M&Aディール及び事業提携情報
    Summary Gazprom is an integrated global oil and gas company. It carries out the exploration, production, transportation, storage, processing and marketing of natural gas, gas condensate and crude oil. The company also sells gas as a vehicle fuel and participates in the generation and marketing of he …
  • Taita Chemical Co, Ltd (1309):企業の財務・戦略的SWOT分析
    Taita Chemical Co, Ltd (1309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆